3
项与 CAR.70/IL15-transduced CB-NK cells(M.D. Anderson Cancer Center) 相关的临床试验Phase I/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
To find a recommended dose of donated NK cells that can be given with lymphodepleting chemotherapy to patients with advanced renal cell carcinoma, mesothelioma, or osteosarcoma. The effects of this therapy will also be studied.
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
The goal of this clinical research study is to learn about the safety of giving immune cells called natural killer (NK) cells with chemotherapy to patients with leukemia, lymphoma, or multiple myeloma.
Immune system cells (such as NK cells) are made by the body to attack foreign or cancerous cells. Researchers think that NK cells you receive from a donor may react against cancer cells in your body, which may help to control the disease.
Clinical Study of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)
100 项与 CAR.70/IL15-transduced CB-NK cells(M.D. Anderson Cancer Center) 相关的临床结果
100 项与 CAR.70/IL15-transduced CB-NK cells(M.D. Anderson Cancer Center) 相关的转化医学
100 项与 CAR.70/IL15-transduced CB-NK cells(M.D. Anderson Cancer Center) 相关的专利(医药)
100 项与 CAR.70/IL15-transduced CB-NK cells(M.D. Anderson Cancer Center) 相关的药物交易